GEODE CAPITAL MANAGEMENT, LLC - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 26 filers reported holding LANTERN PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q3 2023$324,141
-36.2%
95,036
+5.6%
0.00%
Q2 2023$507,746
+82.0%
90,026
+55.8%
0.00%
Q1 2023$279,048
+80086.2%
57,7740.0%0.00%
Q4 2022$348
-99.9%
57,774
-0.2%
0.00%
Q3 2022$276,000
-15.9%
57,909
+0.6%
0.00%
Q2 2022$328,000
-19.4%
57,564
+0.9%
0.00%
Q1 2022$407,000
-10.5%
57,0430.0%0.00%
Q4 2021$455,000
-28.6%
57,0430.0%0.00%
Q3 2021$637,000
-21.3%
57,043
+2.8%
0.00%
Q2 2021$809,000
-2.6%
55,479
+21.1%
0.00%
Q1 2021$831,00045,8300.00%
Other shareholders
LANTERN PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
CM Management, LLC 75,000$255,7500.27%
Redmond Asset Management, LLC 46,506$158,5850.06%
Pathway Financial Advisors LLC 32,771$111,7490.04%
CARLSON CAPITAL L P 95,000$323,9500.02%
NewEdge Advisors, LLC 170,031$579,8280.01%
WOLFF WIESE MAGANA LLC 2,200$7,5020.01%
Meridian Wealth Management, LLC 16,660$56,8110.00%
Sigma Planning Corp 18,125$61,8060.00%
HORIZON KINETICS ASSET MANAGEMENT LLC 30,000$102,3000.00%
WELLS FARGO & COMPANY/MN 4,492$15,3180.00%
View complete list of LANTERN PHARMA INC shareholders